Dexamethasone mediates protection against acute pancreatitis via upregulation of pancreatitis-associated proteins

Emad Kandil, Yin Yao Lin, Martin H. Bluth, Hong Zhang, Michael E. Zenilman, Gabriel Levi

Research output: Contribution to journalArticle

Abstract

Aim: To examine the influence of dexamethasone on pancreatitis-associated protein (PAP) gene expression using both in vitro and in vivo models of acute pancreatitis and to study how PAP gene expression correlates with severity of pancreatitis. Methods: In vitro, IL-6 stimulated pancreas acinar AR42J cells were cultured with increasing concentrations of dexamethasone and assayed for PAP expression (RT-PCR). In vivo, pancreatitis was induced in rats by retrograde injection of 40 g/L taurocholate into the pancreatic duct. Animals were pretreated with dexamethasone (2 mg/kg) daily or saline for 4 d. Pancreata and serum were harvested after 24 h and gene expression levels of PAP I, II and III were measured by RT-PCR. Severity of pancreatitis was based on serum amylase, pancreatic wet weight, and histopathological score. Results: In vitro, dexamethasone and IL-6 induced a marked transcription of PAP I, II and III genes in AR42J cells at 24 h (P <0.05 for all comparisons). In vivo, pancreas mRNA levels of PAP I, II or III increased by 2.6-fold, 1.9-fold, and 1.3-fold respectively after dexamethasone treatment, compared with saline treated animals. Serum amylase levels and edema were significantly lower in the dexamethasone group compared with the saline group. Histopathologic evaluation revealed less inflammation and necrosis in pancreata obtained from dexamethasone treated animals (P <0.05). Conclusion: Dexamethasone significantly decreases the severity of pancreatitis. The protective mechanism of dexamethasone may be via upregulating PAP gene expression during injury.

Original languageEnglish (US)
Pages (from-to)6806-6811
Number of pages6
JournalWorld Journal of Gastroenterology
Volume12
Issue number42
StatePublished - Nov 14 2006
Externally publishedYes

Fingerprint

Pancreatitis
Dexamethasone
Up-Regulation
Pancreas
Gene Expression
Amylases
Interleukin-6
Serum
pancreatitis-associated protein
Polymerase Chain Reaction
Taurocholic Acid
Acinar Cells
Pancreatic Ducts
Edema
Necrosis
Inflammation
Weights and Measures
Messenger RNA
Injections
Wounds and Injuries

Keywords

  • Dexamethasone
  • Pancreatitis
  • Pancreatitis-associated protein

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Kandil, E., Lin, Y. Y., Bluth, M. H., Zhang, H., Zenilman, M. E., & Levi, G. (2006). Dexamethasone mediates protection against acute pancreatitis via upregulation of pancreatitis-associated proteins. World Journal of Gastroenterology, 12(42), 6806-6811.

Dexamethasone mediates protection against acute pancreatitis via upregulation of pancreatitis-associated proteins. / Kandil, Emad; Lin, Yin Yao; Bluth, Martin H.; Zhang, Hong; Zenilman, Michael E.; Levi, Gabriel.

In: World Journal of Gastroenterology, Vol. 12, No. 42, 14.11.2006, p. 6806-6811.

Research output: Contribution to journalArticle

Kandil, E, Lin, YY, Bluth, MH, Zhang, H, Zenilman, ME & Levi, G 2006, 'Dexamethasone mediates protection against acute pancreatitis via upregulation of pancreatitis-associated proteins', World Journal of Gastroenterology, vol. 12, no. 42, pp. 6806-6811.
Kandil, Emad ; Lin, Yin Yao ; Bluth, Martin H. ; Zhang, Hong ; Zenilman, Michael E. ; Levi, Gabriel. / Dexamethasone mediates protection against acute pancreatitis via upregulation of pancreatitis-associated proteins. In: World Journal of Gastroenterology. 2006 ; Vol. 12, No. 42. pp. 6806-6811.
@article{4e243ac5769741ee9b2b0e7116163a09,
title = "Dexamethasone mediates protection against acute pancreatitis via upregulation of pancreatitis-associated proteins",
abstract = "Aim: To examine the influence of dexamethasone on pancreatitis-associated protein (PAP) gene expression using both in vitro and in vivo models of acute pancreatitis and to study how PAP gene expression correlates with severity of pancreatitis. Methods: In vitro, IL-6 stimulated pancreas acinar AR42J cells were cultured with increasing concentrations of dexamethasone and assayed for PAP expression (RT-PCR). In vivo, pancreatitis was induced in rats by retrograde injection of 40 g/L taurocholate into the pancreatic duct. Animals were pretreated with dexamethasone (2 mg/kg) daily or saline for 4 d. Pancreata and serum were harvested after 24 h and gene expression levels of PAP I, II and III were measured by RT-PCR. Severity of pancreatitis was based on serum amylase, pancreatic wet weight, and histopathological score. Results: In vitro, dexamethasone and IL-6 induced a marked transcription of PAP I, II and III genes in AR42J cells at 24 h (P <0.05 for all comparisons). In vivo, pancreas mRNA levels of PAP I, II or III increased by 2.6-fold, 1.9-fold, and 1.3-fold respectively after dexamethasone treatment, compared with saline treated animals. Serum amylase levels and edema were significantly lower in the dexamethasone group compared with the saline group. Histopathologic evaluation revealed less inflammation and necrosis in pancreata obtained from dexamethasone treated animals (P <0.05). Conclusion: Dexamethasone significantly decreases the severity of pancreatitis. The protective mechanism of dexamethasone may be via upregulating PAP gene expression during injury.",
keywords = "Dexamethasone, Pancreatitis, Pancreatitis-associated protein",
author = "Emad Kandil and Lin, {Yin Yao} and Bluth, {Martin H.} and Hong Zhang and Zenilman, {Michael E.} and Gabriel Levi",
year = "2006",
month = "11",
day = "14",
language = "English (US)",
volume = "12",
pages = "6806--6811",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "42",

}

TY - JOUR

T1 - Dexamethasone mediates protection against acute pancreatitis via upregulation of pancreatitis-associated proteins

AU - Kandil, Emad

AU - Lin, Yin Yao

AU - Bluth, Martin H.

AU - Zhang, Hong

AU - Zenilman, Michael E.

AU - Levi, Gabriel

PY - 2006/11/14

Y1 - 2006/11/14

N2 - Aim: To examine the influence of dexamethasone on pancreatitis-associated protein (PAP) gene expression using both in vitro and in vivo models of acute pancreatitis and to study how PAP gene expression correlates with severity of pancreatitis. Methods: In vitro, IL-6 stimulated pancreas acinar AR42J cells were cultured with increasing concentrations of dexamethasone and assayed for PAP expression (RT-PCR). In vivo, pancreatitis was induced in rats by retrograde injection of 40 g/L taurocholate into the pancreatic duct. Animals were pretreated with dexamethasone (2 mg/kg) daily or saline for 4 d. Pancreata and serum were harvested after 24 h and gene expression levels of PAP I, II and III were measured by RT-PCR. Severity of pancreatitis was based on serum amylase, pancreatic wet weight, and histopathological score. Results: In vitro, dexamethasone and IL-6 induced a marked transcription of PAP I, II and III genes in AR42J cells at 24 h (P <0.05 for all comparisons). In vivo, pancreas mRNA levels of PAP I, II or III increased by 2.6-fold, 1.9-fold, and 1.3-fold respectively after dexamethasone treatment, compared with saline treated animals. Serum amylase levels and edema were significantly lower in the dexamethasone group compared with the saline group. Histopathologic evaluation revealed less inflammation and necrosis in pancreata obtained from dexamethasone treated animals (P <0.05). Conclusion: Dexamethasone significantly decreases the severity of pancreatitis. The protective mechanism of dexamethasone may be via upregulating PAP gene expression during injury.

AB - Aim: To examine the influence of dexamethasone on pancreatitis-associated protein (PAP) gene expression using both in vitro and in vivo models of acute pancreatitis and to study how PAP gene expression correlates with severity of pancreatitis. Methods: In vitro, IL-6 stimulated pancreas acinar AR42J cells were cultured with increasing concentrations of dexamethasone and assayed for PAP expression (RT-PCR). In vivo, pancreatitis was induced in rats by retrograde injection of 40 g/L taurocholate into the pancreatic duct. Animals were pretreated with dexamethasone (2 mg/kg) daily or saline for 4 d. Pancreata and serum were harvested after 24 h and gene expression levels of PAP I, II and III were measured by RT-PCR. Severity of pancreatitis was based on serum amylase, pancreatic wet weight, and histopathological score. Results: In vitro, dexamethasone and IL-6 induced a marked transcription of PAP I, II and III genes in AR42J cells at 24 h (P <0.05 for all comparisons). In vivo, pancreas mRNA levels of PAP I, II or III increased by 2.6-fold, 1.9-fold, and 1.3-fold respectively after dexamethasone treatment, compared with saline treated animals. Serum amylase levels and edema were significantly lower in the dexamethasone group compared with the saline group. Histopathologic evaluation revealed less inflammation and necrosis in pancreata obtained from dexamethasone treated animals (P <0.05). Conclusion: Dexamethasone significantly decreases the severity of pancreatitis. The protective mechanism of dexamethasone may be via upregulating PAP gene expression during injury.

KW - Dexamethasone

KW - Pancreatitis

KW - Pancreatitis-associated protein

UR - http://www.scopus.com/inward/record.url?scp=33751379238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751379238&partnerID=8YFLogxK

M3 - Article

C2 - 17106929

AN - SCOPUS:33751379238

VL - 12

SP - 6806

EP - 6811

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 42

ER -